Sperr, W R <br/><br/>
Comorbidity as prognostic variable in MDS: comparative evaluation of the HCT-CI and CCI in a core dataset of 419 patients of the Austrian MDS Study Group.  [electronic resource] 

 -  Annals of oncology : official journal of the European Society for Medical Oncology  Jan 2010 
 - 114-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1569-8041 
<br/><br/><label>Standard No.: </label>10.1093/annonc/mdp258  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Austria<br/>Comorbidity<br/>Disease-Free Survival<br/>Female<br/>Humans<br/>Kaplan-Meier Estimate<br/>Leukemia, Myeloid, Acute--epidemiology<br/>Male<br/>Middle Aged<br/>Myelodysplastic Syndromes--epidemiology<br/>Precancerous Conditions--epidemiology<br/>Prognosis<br/>Retrospective Studies<br/>Young Adult